Pages that link to "Q24647959"
Jump to navigation
Jump to search
The following pages link to Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma (Q24647959):
Displaying 41 items.
- Targeted deletion of Wwox reveals a tumor suppressor function (Q24681190) (← links)
- WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome (Q24815527) (← links)
- Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster (Q27321940) (← links)
- Expression profiling in primates reveals a rapid evolution of human transcription factors (Q28300964) (← links)
- Tumor suppressor and hepatocellular carcinoma (Q28389231) (← links)
- Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review) (Q28394917) (← links)
- Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer (Q28829385) (← links)
- Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk. (Q33585044) (← links)
- Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma (Q33855801) (← links)
- Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias. (Q34083679) (← links)
- WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. (Q34083683) (← links)
- WWOX protein expression in normal human tissues. (Q34089523) (← links)
- Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours (Q34119564) (← links)
- WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies. (Q34120466) (← links)
- Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines (Q34309523) (← links)
- Oncosuppressor proteins of fragile sites are reduced in cervical cancer (Q34330247) (← links)
- Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma (Q35065555) (← links)
- Expression of WW domain-containing oxidoreductase WWOX in pterygium (Q35780471) (← links)
- Common fragile genes and digestive tract cancers (Q36353725) (← links)
- Chronic hepatitis B in hepatocarcinogenesis (Q36557635) (← links)
- The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. (Q36953585) (← links)
- Alteration of WWOX in human cancer: a clinical view. (Q37071040) (← links)
- Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase (Q37071059) (← links)
- Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer (Q37687151) (← links)
- WWOX gene and gene product: tumor suppression through specific protein interactions (Q37690302) (← links)
- WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications (Q38186582) (← links)
- WWOX, large common fragile site genes, and cancer (Q38321093) (← links)
- MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX. (Q38906745) (← links)
- MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer (Q39185993) (← links)
- Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma. (Q39254272) (← links)
- Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. (Q40368333) (← links)
- Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines (Q40414760) (← links)
- Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas. (Q41838085) (← links)
- The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype (Q42470405) (← links)
- Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells. (Q50908933) (← links)
- WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia. (Q55003004) (← links)
- Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. (Q55042166) (← links)
- Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue (Q58702230) (← links)
- Loss of WWOX expression in human extrahepatic cholangiocarcinoma (Q81646239) (← links)
- Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer (Q83785212) (← links)
- Pleiotropic tumor suppressor functions of WWOX antagonize metastasis (Q91999274) (← links)